✦ LIBER ✦

IgG formation to mammalian proteins in hemophilia A patients following treatment with a new recombinant human factor VIII

✍ Scribed by P. Larson; C. Zhang; E. Gorina; E. Burmeister Getz

Book ID: 109148358
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 356 KB
Volume: 2
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2004.00727.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Clinical evaluation of a rec

Erratum to: Clinical evaluation of a recombinant factor VIII preparation (kogenate) in previously untreated patients with hemophilia A

✍ A. Yoshioka; K. Fukutake; J. Takamatsu; A. Shirahata 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 22 KB

Human recombinant DNA-derived antihemoph

Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation

✍ J. Lusher; C. Abildgaard; S. Arkin; P. M. Mannucci; R. Zimmermann; L. Schwartz; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

A prospective surveillance study of fact

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose

✍ M. RUBINGER; D. LILLICRAP; G. E. RIVARD; J. TEITEL; M. CARCAO; C. HENSMAN; I. WA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Successful use of recombinant factor VII

Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity

✍ Raymond G. Watts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

Activated recombinant human coagulation

Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

✍ Liebman, Howard A.; Chediak, Juan; Fink, Kenneth I.; Galvez, Angel G.; Shah, Pra 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Eight patients with inhibitors to factor VIII (4 hemophilia A and 4 nonhemophilic) were treated with recombinant activated factor VII (rFVIIa) to control severe abdominal bleeding. The recombinant factor was supplied under an open-label, emergency-use program to patients previously unresponsive to o

Low risk of inhibitor formation in haemo

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®)

✍ C. L. BACON; E. SINGLETON; B. BRADY; B. WHITE; B. NOLAN; R. M. GILMORE; C. RYAN; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB